(R)-Crizotinib-d5 (piperidine-2,2,4,6,6-d5)

SL-1360

(R)-Crizotinib-d₅ (piperidine-2,2,4,6,6-d₅), >98% (CP)

Isotopic Purity : 98 atom % D

CAS No. : [1395950-48-7]

Related CAS No. : [877399-52-5] of the unlabelled compound

Synonyms : PF 02341066-d₅; PF 2341066-d₅

IUPAC Name : 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-d₅)-1H-pyrazol-4-yl]-2-pyridinamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a deuterium labelled version of Crizotinib, which is a potent inhibitor of c-Met and ALK. Crizotinib is an anti-cancer drug, used for the treatment of non-small cell lung carcinoma (NSCLC). It can be used as an analytical reference standard.

References : Tucker E. R. et al.: Mol. Oncol., 11(8), 996, 2017; Liu H. et al.: Cancer Discov., 8(3), 354, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.